• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53恢复在衰老诱导和维持中的作用:在前癌细胞和恶性肿瘤细胞中的不同效应

p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells.

作者信息

Harajly Mohamad, Zalzali Hasan, Nawaz Zafar, Ghayad Sandra E, Ghamloush Farah, Basma Hussein, Zainedin Samiha, Rabeh Wissam, Jabbour Mark, Tawil Ayman, Badro Danielle A, Evan Gerard I, Saab Raya

机构信息

Department of Pediatric and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Cytogenetics and Molecular Cytogenetic Laboratory, Hamad General Hospital, Doha, Qatar.

出版信息

Mol Cell Biol. 2015 Nov 23;36(3):438-51. doi: 10.1128/MCB.00747-15. Print 2016 Feb 1.

DOI:10.1128/MCB.00747-15
PMID:26598601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4719431/
Abstract

The restoration of p53 has been suggested as a therapeutic approach in tumors. However, the timing of p53 restoration in relation to its efficacy during tumor progression still is unclear. We now show that the restoration of p53 in murine premalignant proliferating pineal lesions resulted in cellular senescence, while p53 restoration in invasive pineal tumors did not. The effectiveness of p53 restoration was not dependent on p19(Arf) expression but showed an inverse correlation with Mdm2 expression. In tumor cells, p53 restoration became effective when paired with either DNA-damaging therapy or with nutlin, an inhibitor of p53-Mdm2 interaction. Interestingly, the inactivation of p53 after senescence resulted in reentry into the cell cycle and rapid tumor progression. The evaluation of a panel of human supratentorial primitive neuroectodermal tumors (sPNET) showed low activity of the p53 pathway. Together, these data suggest that the restoration of the p53 pathway has different effects in premalignant versus invasive pineal tumors, and that p53 activation needs to be continually sustained, as reversion from senescence occurs rapidly with aggressive tumor growth when p53 is lost again. Finally, p53 restoration approaches may be worth exploring in sPNET, where the p53 gene is intact but the pathway is inactive in the majority of examined tumors.

摘要

恢复p53功能已被提议作为一种肿瘤治疗方法。然而,p53功能恢复的时机与其在肿瘤进展过程中的疗效之间的关系仍不明确。我们现在发现,在小鼠松果体癌前增殖性病变中恢复p53功能会导致细胞衰老,而在侵袭性松果体肿瘤中恢复p53功能则不会。p53功能恢复的有效性并不依赖于p19(Arf)的表达,而是与Mdm2的表达呈负相关。在肿瘤细胞中,当p53功能恢复与DNA损伤疗法或与p53-Mdm2相互作用抑制剂nutlin联合使用时,变得有效。有趣的是,衰老后p53失活会导致细胞重新进入细胞周期并使肿瘤快速进展。对一组人类幕上原始神经外胚层肿瘤(sPNET)的评估显示,p53通路活性较低。总之,这些数据表明,p53通路的恢复在松果体癌前肿瘤和侵袭性肿瘤中具有不同的作用,并且p53激活需要持续维持,因为当p53再次缺失时,随着肿瘤的快速生长,衰老会迅速逆转。最后,在p53基因完整但在大多数检测肿瘤中该通路无活性的sPNET中,恢复p53功能的方法可能值得探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/be33c436e17a/zmb9991011020008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/9d0ebd812397/zmb9991011020001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/599d379b2b5d/zmb9991011020002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/f18d62ce34a6/zmb9991011020003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/0c8843205039/zmb9991011020004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/f17395a7191f/zmb9991011020005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/be33c436e17a/zmb9991011020008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/9d0ebd812397/zmb9991011020001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/599d379b2b5d/zmb9991011020002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/f18d62ce34a6/zmb9991011020003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/0c8843205039/zmb9991011020004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/f17395a7191f/zmb9991011020005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bc/4719431/be33c436e17a/zmb9991011020008.jpg

相似文献

1
p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells.p53恢复在衰老诱导和维持中的作用:在前癌细胞和恶性肿瘤细胞中的不同效应
Mol Cell Biol. 2015 Nov 23;36(3):438-51. doi: 10.1128/MCB.00747-15. Print 2016 Feb 1.
2
p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.p18Ink4c和p53在细胞周期蛋白D1驱动的原始神经外胚层肿瘤中作为肿瘤抑制因子发挥作用。
Cancer Res. 2009 Jan 15;69(2):440-8. doi: 10.1158/0008-5472.CAN-08-1892.
3
Constitutional t(16;22)(p13.3;q11.2 approximately 12) in a primitive neuroectodermal tumor of the pineal region.松果体区原始神经外胚层肿瘤中的染色体组型t(16;22)(p13.3;q11.2,约12)
Cancer Genet Cytogenet. 2003 Apr 1;142(1):73-6. doi: 10.1016/s0165-4608(02)00735-5.
4
MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.MRI 特征与分子诊断和预后相关的组织学诊断的幕上原始神经外胚层肿瘤和松果体母细胞瘤:来自儿童肿瘤学组 ACNS0332 试验的报告。
AJNR Am J Neuroradiol. 2019 Nov;40(11):1796-1803. doi: 10.3174/ajnr.A6253. Epub 2019 Oct 10.
5
Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.中枢神经系统原始神经外胚层肿瘤和松果体母细胞瘤的全基因组分子特征分析。
Neuro Oncol. 2011 Aug;13(8):866-79. doi: 10.1093/neuonc/nor070.
6
The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis.MDM2的一种剪接变体MDM2-a在体外改变转化,并在Arf和p53缺失的肿瘤发生模型中改变肿瘤谱。
Mol Cancer Res. 2009 Jun;7(6):863-9. doi: 10.1158/1541-7786.MCR-08-0418. Epub 2009 Jun 2.
7
Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.Nutlin-3a(一种MDM2拮抗剂)激活p53可诱导成人T细胞白血病细胞发生凋亡和细胞衰老。
Leukemia. 2009 Nov;23(11):2090-101. doi: 10.1038/leu.2009.171. Epub 2009 Aug 27.
8
Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.Slp65 缺陷前 B 细胞的恶性转化涉及到 Arf-Mdm2-p53 肿瘤抑制途径的破坏。
Blood. 2010 Feb 18;115(7):1385-93. doi: 10.1182/blood-2009-05-222166. Epub 2009 Dec 14.
9
Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on MDM2 antagonism.Nutlin-3 诱导肾癌细胞衰老:一种基于 MDM2 拮抗的潜在治疗策略。
Cancer Lett. 2014 Oct 28;353(2):211-9. doi: 10.1016/j.canlet.2014.07.024. Epub 2014 Jul 24.
10
Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.药物抑制 Mdm2 会引发小鼠结肠肿瘤和人结肠癌细胞的生长停滞,并促进 DNA 断裂。
Mol Carcinog. 2012 May;51(5):363-78. doi: 10.1002/mc.20795. Epub 2011 May 6.

引用本文的文献

1
An imbalance between proliferation and differentiation underlies the development of microRNA-defective pineoblastoma.增殖与分化之间的失衡是微小RNA缺陷型松果体母细胞瘤发生发展的基础。
Genes Dev. 2025 Apr 16. doi: 10.1101/gad.352485.124.
2
An imbalance between proliferation and differentiation underlies the development of microRNA-defective pineoblastoma.增殖与分化之间的失衡是微小RNA缺陷型松果体母细胞瘤发生发展的基础。
bioRxiv. 2024 Oct 22:2024.04.23.590638. doi: 10.1101/2024.04.23.590638.
3
Senescence and senolysis in cancer: The latest findings.

本文引用的文献

1
Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy.治疗诱导的细胞周期动力学决定肿瘤对化疗的反应。
Oncotarget. 2015 Mar 30;6(9):7040-52. doi: 10.18632/oncotarget.3140.
2
Pharmacological reactivation of p53 as a strategy to treat cancer.作为治疗癌症的策略,药理学激活 p53。
J Intern Med. 2015 Feb;277(2):248-259. doi: 10.1111/joim.12336.
3
p53 as a target for the treatment of cancer.p53 作为癌症治疗的靶点。
衰老和衰老细胞清除在癌症中的作用:最新研究发现。
Cancer Sci. 2024 Jul;115(7):2107-2116. doi: 10.1111/cas.16184. Epub 2024 Apr 19.
4
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research.与 ChatGPT 就衰老和癌症研究中的争议问题进行对话。
Mol Pharmacol. 2024 Apr 17;105(5):313-327. doi: 10.1124/molpharm.124.000871.
5
A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements.松果体母细胞瘤染色质可及性和表达谱的时间分辨体内目录揭示了抑制元件的普遍作用。
Genome Res. 2023 Feb;33(2):269-282. doi: 10.1101/gr.277037.122. Epub 2023 Jan 17.
6
A Novel ERK2 Degrader Z734 Induces Apoptosis of MCF-7 Cells via the HERC3/p53 Signaling Pathway.一种新型 ERK2 降解剂 Z734 通过 HERC3/p53 信号通路诱导 MCF-7 细胞凋亡。
Molecules. 2022 Jul 6;27(14):4337. doi: 10.3390/molecules27144337.
7
The Paradoxical Role of Cellular Senescence in Cancer.细胞衰老在癌症中的矛盾作用。
Front Cell Dev Biol. 2021 Aug 12;9:722205. doi: 10.3389/fcell.2021.722205. eCollection 2021.
8
Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy.新兴的自噬功能塑造肿瘤微环境并在癌症进展中发挥作用——对癌症治疗的启示。
Front Oncol. 2020 Nov 25;10:606436. doi: 10.3389/fonc.2020.606436. eCollection 2020.
9
Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes -deficient cancers to mTOR inhibition.合成信使核糖核酸纳米颗粒介导的p53肿瘤抑制因子恢复使p53缺陷型癌症对雷帕霉素靶蛋白抑制敏感。
Sci Transl Med. 2019 Dec 18;11(523). doi: 10.1126/scitranslmed.aaw1565.
10
Cellular senescence: a promising strategy for cancer therapy.细胞衰老:癌症治疗的一种有前途的策略。
BMB Rep. 2019 Jan;52(1):35-41. doi: 10.5483/BMBRep.2019.52.1.294.
Cancer Treat Rev. 2014 Dec;40(10):1153-60. doi: 10.1016/j.ctrv.2014.10.004.
4
Inside and out: the activities of senescence in cancer.内外兼修:衰老在癌症中的作用。
Nat Rev Cancer. 2014 Aug;14(8):547-58. doi: 10.1038/nrc3773. Epub 2014 Jul 17.
5
Cellular senescence: from physiology to pathology.细胞衰老:从生理学到病理学。
Nat Rev Mol Cell Biol. 2014 Jul;15(7):482-96. doi: 10.1038/nrm3823.
6
Drugging the p53 pathway: understanding the route to clinical efficacy.靶向 p53 通路:探索通往临床疗效的途径。
Nat Rev Drug Discov. 2014 Mar;13(3):217-36. doi: 10.1038/nrd4236.
7
The Mdm network and its regulation of p53 activities: a rheostat of cancer risk.Mdm网络及其对p53活性的调控:癌症风险的变阻器
Hum Mutat. 2014 Jun;35(6):728-37. doi: 10.1002/humu.22524. Epub 2014 Mar 6.
8
Cellular senescence and its effector programs.细胞衰老及其效应程序。
Genes Dev. 2014 Jan 15;28(2):99-114. doi: 10.1101/gad.235184.113.
9
Nutlin-3 induces HO-1 expression by activating JNK in a transcription-independent manner of p53.Nutlin-3 通过非依赖转录因子 p53 的方式激活 JNK 诱导 HO-1 的表达。
Int J Oncol. 2014 Mar;44(3):761-8. doi: 10.3892/ijo.2013.2227. Epub 2013 Dec 23.
10
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer.利用 nutlin 疗法激活野生型 p53 治疗儿童癌症。
Cancer Lett. 2014 Mar 28;344(2):157-65. doi: 10.1016/j.canlet.2013.11.002. Epub 2013 Nov 18.